Analyst Reco. Novo Nordisk A/S

Equities

Market Closed - Nasdaq Copenhagen Other stock markets 10:59:47 2024-04-30 am EDT			5-day change	1st Jan Change
902.6 ^DKK	+2.01%		+3.12%	+29.29%

Apr. 30	FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications	MT
Apr. 30	Sector Update: Health Care Stocks Mixed Late Afternoon	MT

NOVO NORDISK : UBS sticks Neutral	Apr. 29	ZD
NOVO NORDISK : JP Morgan gives a Buy rating	Apr. 25	ZD
NOVO NORDISK : Bernstein maintains a Buy rating	Apr. 24	ZD
BMO Capital Starts Novo Nordisk With Outperform Rating, $163 Price Target	Apr. 12	MT
NOVO NORDISK : UBS sticks Neutral	Mar. 26	ZD
NOVO NORDISK : Barclays maintains a Buy rating	Mar. 25	ZD
NOVO NORDISK : Berenberg remains Neutral	Mar. 18	ZD
NOVO NORDISK : Novo’s bag is full of pearls!	Mar. 15
NOVO NORDISK : Barclays reiterates its Buy rating	Mar. 11	ZD
NOVO NORDISK : UBS sticks Neutral	Mar. 11	ZD
NOVO NORDISK : JP Morgan reaffirms its Buy rating	Mar. 08	ZD
NOVO NORDISK : Deutsche Bank reiterates its Buy rating	Mar. 08	ZD
NOVO NORDISK : Novo’s got a strong arsenal to go the distance	Mar. 08
NOVO NORDISK : Buy rating from Barclays	Mar. 07	ZD
NOVO NORDISK : Receives a Buy rating from Deutsche Bank	Mar. 06	ZD
NOVO NORDISK : JP Morgan reiterates its Buy rating	Mar. 05	ZD
NOVO NORDISK : UBS reiterates its Neutral rating	Mar. 05	ZD
NOVO NORDISK : Receives a Buy rating from Deutsche Bank	Mar. 01	ZD
NOVO NORDISK : Receives a Buy rating from Deutsche Bank	Feb. 28	ZD
NOVO NORDISK : UBS reiterates its Neutral rating	Feb. 27	ZD